The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial
Abulmeaty, M.M.A.; Aljuraiban, G.S.; Shaikh, S.M.; ALEid, N.E.; Mazrou, L.R.A.; Turjoman, A.A.; Aldosari, M.S.; Razak, S.; El-Sayed, M.M.; Areabi, T.M.; Alsalafi, R.M.; Al-Helio, Y.S.; Almutairy, A.B.; Molla, H.N. The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial. Antioxidants 2021, 10, 804. https://doi.org/10.3390/antiox10050804
Abulmeaty MMA, Aljuraiban GS, Shaikh SM, ALEid NE, Mazrou LRA, Turjoman AA, Aldosari MS, Razak S, El-Sayed MM, Areabi TM, Alsalafi RM, Al-Helio YS, Almutairy AB, Molla HN. The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial. Antioxidants. 2021; 10(5):804. https://doi.org/10.3390/antiox10050804
Chicago/Turabian StyleAbulmeaty, Mahmoud M. A., Ghadeer S. Aljuraiban, Sumaya M. Shaikh, Naif E. ALEid, Lulwa R. Al Mazrou, Abdullah A. Turjoman, Mona S. Aldosari, Suhail Razak, Mervat M. El-Sayed, Tahani M. Areabi, Rokia M. Alsalafi, Yasser S. Al-Helio, Abdulrhman B. Almutairy, and Haneen N. Molla. 2021. "The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial" Antioxidants 10, no. 5: 804. https://doi.org/10.3390/antiox10050804